Study could pave the way for synergistic therapeutic combinations to better treat SF3B1-mutant MDS

A new study from researchers with Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine and collaborating organizations provides insight into the underlying mechanisms of gene mutations commonly seen in patients with myelodysplastic syndromes (MDS) and other myeloid neoplasms.

Avacta partners Tempus to boost development of cancer therapies

The platform targets tumour-specific protease to concentrate potent treatments within the tumour microenvironment. Credit: MUNGKHOOD STUDIO/Shutterstock. Avacta Therapeutics has entered a strategic collaboration with Tempus

October 22, 2024

Researchers identify key osteoporosis-related gene and develop new mouse model of the disease

Osteoporosis-;weakening of the bones with age-;affects millions worldwide, and this figure is increasing annually as the global population ages.

July 2, 2024

6 races to watch that could shape health care policy

WASHINGTON — Election season will bring a reckoning for members who took controversial positions on health care issues over the past year, and an opportunity

October 29, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.